TLK286

DRUG6 trials

Sponsors

Telik

Conditions

Breast NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Non-small-cell LungOvarian Neoplasms

Phase 1

TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer

CompletedNCT00051948

TelikOvarian Neoplasms

Start: 2003-01-31End: 2005-01-31Target: 28Updated: 2011-07-25

TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer

CompletedNCT00052065

TelikOvarian Neoplasms

Start: 2003-02-28End: 2006-03-31Target: 28Updated: 2011-07-25

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

CompletedNCT00088556

TelikCarcinoma, Non-Small-Cell Lung

Start: 2004-08-31End: 2009-05-31Updated: 2012-05-31

Phase 2

Phase 2 Study of TLK286 in Metastatic Breast Cancer

CompletedNCT00035841

TelikBreast Neoplasms

Start: 2002-04-30End: 2004-07-31Target: 60Updated: 2011-07-25

Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer

CompletedNCT00038428

TelikOvarian Neoplasms

Start: 2001-06-30End: 2005-07-31Target: 40Updated: 2011-07-25

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

CompletedNCT00040638

TelikCarcinoma, Non-small-cell Lung

Start: 2002-07-31End: 2003-08-31Target: 40Updated: 2011-07-25